5 Stocks Pushing The Health Services Industry Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 82 points (-0.5%) at 15,473 as of Friday, July 26, 2013, 12:49 PM ET. The NYSE advances/declines ratio sits at 1,028 issues advancing vs. 1,878 declining with 105 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the industry include Health Net ( HNT), down 4.2%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.9%, Humana ( HUM), down 1.4%, WellPoint ( WLP), down 1.2% and Catamaran ( CTRX), down 0.8%. Top gainers within the industry include HCA Holdings ( HCA), up 2.4%, Zimmer Holdings ( ZMH), up 1.4%, Grifols ( GRFS), up 1.1% and Intuitive Surgical ( ISRG), up 1.0%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Mettler-Toledo International ( MTD) is one of the companies pushing the Health Services industry lower today. As of noon trading, Mettler-Toledo International is down $5.76 (-2.6%) to $217.29 on heavy volume. Thus far, 170,731 shares of Mettler-Toledo International exchanged hands as compared to its average daily volume of 175,500 shares. The stock has ranged in price between $210.88-$222.86 after having opened the day at $220.71 as compared to the previous trading day's close of $223.05.

Mettler-Toledo International Inc. supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. Mettler-Toledo International has a market cap of $6.7 billion and is part of the health care sector. Shares are up 14.9% year to date as of the close of trading on Thursday. Currently there are 2 analysts that rate Mettler-Toledo International a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, notable return on equity, good cash flow from operations, growth in earnings per share and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Mettler-Toledo International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, CareFusion ( CFN) is down $0.58 (-1.5%) to $38.14 on light volume. Thus far, 667,231 shares of CareFusion exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $38.12-$38.60 after having opened the day at $38.54 as compared to the previous trading day's close of $38.72.

CareFusion Corporation provides various healthcare products and services in the United States and internationally. It operates in two segments, Medical Systems and Procedural Solutions. CareFusion has a market cap of $8.5 billion and is part of the health care sector. Shares are up 35.5% year to date as of the close of trading on Thursday. Currently there are 6 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full CareFusion Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Cigna ( CI) is down $0.81 (-1.0%) to $77.19 on light volume. Thus far, 577,089 shares of Cigna exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $76.74-$78.20 after having opened the day at $77.57 as compared to the previous trading day's close of $78.00.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $22.3 billion and is part of the health care sector. Shares are up 45.9% year to date as of the close of trading on Thursday. Currently there are 9 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cigna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Agilent Technologies ( A) is down $0.68 (-1.5%) to $45.98 on light volume. Thus far, 1.2 million shares of Agilent Technologies exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $45.65-$46.56 after having opened the day at $46.32 as compared to the previous trading day's close of $46.66.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $16.1 billion and is part of the health care sector. Shares are up 14.0% year to date as of the close of trading on Thursday. Currently there are 13 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Aetna ( AET) is down $0.84 (-1.3%) to $64.74 on average volume. Thus far, 1.3 million shares of Aetna exchanged hands as compared to its average daily volume of 3.0 million shares. The stock has ranged in price between $64.26-$65.54 after having opened the day at $65.44 as compared to the previous trading day's close of $65.58.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $21.4 billion and is part of the health care sector. Shares are up 41.6% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Aetna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

Health Care and Pharma Feeling the Wrath of Trump: Cramer's 'Mad Money' Recap (Wednesday 1/11/17)

Health Care and Pharma Feeling the Wrath of Trump: Cramer's 'Mad Money' Recap (Wednesday 1/11/17)

Berkshire Hathaway, SAP, Dominion Resources: 'Mad Money' Lightning Round

Berkshire Hathaway, SAP, Dominion Resources: 'Mad Money' Lightning Round

These 5 Health Care Stocks Are Breaking Out This Christmas

These 5 Health Care Stocks Are Breaking Out This Christmas

Analysts' Actions -- AK Steel, Mettler-Toledo, Pure Storage, Phillips 66 and More

Analysts' Actions -- AK Steel, Mettler-Toledo, Pure Storage, Phillips 66 and More